GC Pharma has received approval for a Phase 2 trial of its COVID-19 mRNA vaccine candidate GC4006A and plans to advance toward Phase 3 while expanding the platform into other disease areas.

Last month, a significant riot by North Korean workers in China over unpaid wages hinted at the emergence of a potential labor movement within North Korea.

SK Plasma signs a €65M tech transfer deal with Turkey to boost local production of essential medicines, enhancing global healthcare access.